Page last updated: 2024-09-04

2-(1-octynyl)adenosine and Reperfusion Injury

2-(1-octynyl)adenosine has been researched along with Reperfusion Injury in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aihara, K; Kogi, K; Sasamori, J; Sato, I; Takeo, S; Yoneyama, F1
Harada, N; Katsuragi, T; Okajima, K1
Harada, N; Katsuragi, T; Murakami, K; Ohshima, K; Okajima, K; Sato, C; Usune, S1

Other Studies

3 other study(ies) available for 2-(1-octynyl)adenosine and Reperfusion Injury

ArticleYear
Amelioration of ischemia/reperfusion-induced myocardial infarction by the 2-alkynyladenosine derivative 2-octynyladenosine (YT-146).
    Journal of cardiovascular pharmacology, 2006, Volume: 47, Issue:4

    Topics: Adenosine; Alkynes; Animals; Biomarkers; Blood Pressure; Cardiotonic Agents; Coronary Circulation; Creatine Kinase; Dogs; Female; Heart Rate; Hemodynamics; Ischemic Preconditioning; Male; Myocardial Infarction; Myocardium; Necrosis; Receptors, Adenosine A2; Reperfusion Injury

2006
[Adenosine reduces ischemia/reperfusion-induced liver injury by inhibiting leukocyte activation].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1999, Volume: 114 Suppl 1

    Topics: Adenosine; Alkynes; Animals; Humans; In Vitro Techniques; Leukocyte Elastase; Liver; Male; Monocytes; N-Formylmethionine Leucyl-Phenylalanine; Neutrophil Activation; Neutrophils; Rats; Rats, Wistar; Receptors, Purinergic P1; Reperfusion Injury; Transaminases; Triazines; Triazoles; Tumor Necrosis Factor-alpha

1999
Adenosine and selective A(2A) receptor agonists reduce ischemia/reperfusion injury of rat liver mainly by inhibiting leukocyte activation.
    The Journal of pharmacology and experimental therapeutics, 2000, Volume: 294, Issue:3

    Topics: Adenosine; Alkynes; Animals; Calcium; Cells, Cultured; Chemokine CXCL1; Chemokines, CXC; Chemotactic Factors; Growth Substances; Humans; Intercellular Signaling Peptides and Proteins; Ischemia; Leukocyte Elastase; Lipopolysaccharides; Liver; Male; Monocytes; Neutrophil Activation; Peroxidase; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptor, Adenosine A2A; Reperfusion Injury; Triazines; Triazoles; Tumor Necrosis Factor-alpha

2000